20190321 - Challenges - Novartis Part 1 · 2019. 3. 26. · de ventes Entresto (insurfisance...

2
26/03/2019 1/1

Transcript of 20190321 - Challenges - Novartis Part 1 · 2019. 3. 26. · de ventes Entresto (insurfisance...

Page 1: 20190321 - Challenges - Novartis Part 1 · 2019. 3. 26. · de ventes Entresto (insurfisance cardiaque), Promacta (anómie apla- sique sóvère), Xolair et Mekinist (cancer). Il en

26/03/2019

1/1

Page 2: 20190321 - Challenges - Novartis Part 1 · 2019. 3. 26. · de ventes Entresto (insurfisance cardiaque), Promacta (anómie apla- sique sóvère), Xolair et Mekinist (cancer). Il en

prescriere medicament... · medicamente flind de pana la 30-31 de zile. Programul de carduri prin care produsul Mekinist va fl Oferit gratuit pacientilor initiati cu Tafinlar de catre

prescriere medicament... · medicamente flind de pana la 30-31 de zile. Programul de carduri prin care produsul Mekinist va fl Oferit gratuit pacientilor initiati cu Tafinlar de catre

THERE ARE A FEW WAYS I CAN FIT PROmACTA INTO mY DAY. · IMPORTANT SAFETY INFORMATION FOR PROMACTA® (eltrombopag) (continued) • are pregnant or plan to become pregnant. It is not

THERE ARE A FEW WAYS I CAN FIT PROmACTA INTO mY DAY. · IMPORTANT SAFETY INFORMATION FOR PROMACTA® (eltrombopag) (continued) • are pregnant or plan to become pregnant. It is not

MEKINIST APRESENTAÇÕES VIA ORAL · 2020. 7. 2. · foi aproximadamente 7 meses mais longa do que para monoterapia com dabrafenibe (25,8 meses versus 18,7 meses), com taxas de sobrevida

MEKINIST APRESENTAÇÕES VIA ORAL · 2020. 7. 2. · foi aproximadamente 7 meses mais longa do que para monoterapia com dabrafenibe (25,8 meses versus 18,7 meses), com taxas de sobrevida

207027Orig1s000 - Food and Drug Administration...Sent: Monday, August 17, 2015 4:12 PM To: dennis.williams@novartis.com Cc: Miller, Mara Bauman Subject: NDA 207027 Promacta: FDA requests:

207027Orig1s000 - Food and Drug Administration...Sent: Monday, August 17, 2015 4:12 PM To: [email protected] Cc: Miller, Mara Bauman Subject: NDA 207027 Promacta: FDA requests:

Product: PROMACTA® eltrombopag CASE4913/IRB14-147 STUDY ...

Product: PROMACTA® eltrombopag CASE4913/IRB14-147 STUDY ...

20190321 Informe Metodologico 2018 la movilidad internacional de viajeros y mercancías las unidades empleadas son viajeros y toneladas, respectivamente. En el análisis de la movilidad

20190321 Informe Metodologico 2018 la movilidad internacional de viajeros y mercancías las unidades empleadas son viajeros y toneladas, respectivamente. En el análisis de la movilidad

TAFINLAR + MEKINIST - Novartis · MEKINIST TAFINLAR MEKINIST TAFINLAR 25.1 VS 9.3 VS MONTHS 18.7 MONTHS 8.8 ... be used to treat people who already have received a …

TAFINLAR + MEKINIST - Novartis · MEKINIST TAFINLAR MEKINIST TAFINLAR 25.1 VS 9.3 VS MONTHS 18.7 MONTHS 8.8 ... be used to treat people who already have received a …

berkas.dpr.go.idberkas.dpr.go.id/armus/file/Lampiran/leg_1-20190321-103400-1648.pdf · 2. - Surat M.Pertahanan (Sekdjen) kepada Ketua DPR tgl. 2-5-1959 No. KP/SD/8138/59 tt. Menjampaikan

berkas.dpr.go.idberkas.dpr.go.id/armus/file/Lampiran/leg_1-20190321-103400-1648.pdf · 2. - Surat M.Pertahanan (Sekdjen) kepada Ketua DPR tgl. 2-5-1959 No. KP/SD/8138/59 tt. Menjampaikan

Monthly Campaign Webinar - Together 2 Goaltogether2goal.org/assets/PDF/20190321.pdf · 3/21/2019  · – Use AADE7™ self-care behaviors framework: Healthy Eating, Being Active,

Monthly Campaign Webinar - Together 2 Goaltogether2goal.org/assets/PDF/20190321.pdf · 3/21/2019  · – Use AADE7™ self-care behaviors framework: Healthy Eating, Being Active,

ANEKS I CHARAKTERYSTYKA PRODUKTU LECZNICZEGO · ANEKS I. CHARAKTERYSTYKA PRODUKTU LECZNICZEGO. 2 . 1. NAZWA PRODUKTU LECZNICZEGO. Mekinist 0,5 mg tabletki powlekane . Mekinist 2 mg

ANEKS I CHARAKTERYSTYKA PRODUKTU LECZNICZEGO · ANEKS I. CHARAKTERYSTYKA PRODUKTU LECZNICZEGO. 2 . 1. NAZWA PRODUKTU LECZNICZEGO. Mekinist 0,5 mg tabletki powlekane . Mekinist 2 mg

Should we PROmote PROMACTA® for …sites.utexas.edu/pharmacotherapy-rounds/files/2015/09/heredia11-08...Standard of care for all genotypes: Peg-interferon alfa (PEG) + ribavirin (RBV)

Should we PROmote PROMACTA® for …sites.utexas.edu/pharmacotherapy-rounds/files/2015/09/heredia11-08...Standard of care for all genotypes: Peg-interferon alfa (PEG) + ribavirin (RBV)

RUU. PENGELUARAN PINJAMAN OBLIGASI TAHUN 1959berkas.dpr.go.id/armus/file/Lampiran/leg_1-20190321...2019/03/21  · Undang-undang Padjak Pendapatan 1944 dan dalam pasal 54a ajat 1 dari

RUU. PENGELUARAN PINJAMAN OBLIGASI TAHUN 1959berkas.dpr.go.id/armus/file/Lampiran/leg_1-20190321...2019/03/21  · Undang-undang Padjak Pendapatan 1944 dan dalam pasal 54a ajat 1 dari

CHMP assessment report - European Medicines Agency › en › documents › assessment-report › ... · CHMP assessment report . Mekinist . International non-proprietary name: trametinib

CHMP assessment report - European Medicines Agency › en › documents › assessment-report › ... · CHMP assessment report . Mekinist . International non-proprietary name: trametinib

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · debossed on one face and “TFC” on the opposing face. Mekinist 2 mg film-coated tablets Pink, round, biconvex, film-coated tablets,

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · debossed on one face and “TFC” on the opposing face. Mekinist 2 mg film-coated tablets Pink, round, biconvex, film-coated tablets,

HIGHLIGHTS OF PRESCRIBING INFORMATION • Cardiomyopathy… · 2014-01-09 · 2 FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE . MEKINIST™ as a single agent is indicated

HIGHLIGHTS OF PRESCRIBING INFORMATION • Cardiomyopathy… · 2014-01-09 · 2 FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE . MEKINIST™ as a single agent is indicated

제2공항치중 현공항소음피해 뒷전pdf.ihalla.com/sectionpdf/20190321-78721.pdf · 제주도에따르면팜파스개발사업 는2008년사업시행승인을받았으 며

제2공항치중 현공항소음피해 뒷전pdf.ihalla.com/sectionpdf/20190321-78721.pdf · 제주도에따르면팜파스개발사업 는2008년사업시행승인을받았으 며

Chronic Hepatitis C-associated Thrombocytopenia: Initiate … · For patients with ITP and mild, moderate, or severe hepatic impairment (Child-Pugh Class A, B, C), initiate PROMACTA

Chronic Hepatitis C-associated Thrombocytopenia: Initiate … · For patients with ITP and mild, moderate, or severe hepatic impairment (Child-Pugh Class A, B, C), initiate PROMACTA

Objectives - Amazon Web Servicesdpg-storage.s3.amazonaws.com/ondpg/documents/6136cfc...yDeferasirox (Exjade) – variable absorption with food yEltrombopag (Promacta) – Calcium chelation

Objectives - Amazon Web Servicesdpg-storage.s3.amazonaws.com/ondpg/documents/6136cfc...yDeferasirox (Exjade) – variable absorption with food yEltrombopag (Promacta) – Calcium chelation

HIGHLIGHTS OF PRESCRIBING INFORMATION Chronic …1.3 Treatment of Severe Aplastic Anemia • PROMACTA is indicated in combination with standard immunosuppressive therapy for the first-line

HIGHLIGHTS OF PRESCRIBING INFORMATION Chronic …1.3 Treatment of Severe Aplastic Anemia • PROMACTA is indicated in combination with standard immunosuppressive therapy for the first-line

BANCÁRIOS NA LUTA Ano II | 21 de Março de 2019 | Nº 59 ...seebbauru.org.br/wp-content/uploads/2019/03/20190321-bancarios-… · próximo triênio que o Sindicato realiza uma assembleia

BANCÁRIOS NA LUTA Ano II | 21 de Março de 2019 | Nº 59 ...seebbauru.org.br/wp-content/uploads/2019/03/20190321-bancarios-… · próximo triênio que o Sindicato realiza uma assembleia